Enrique Seoane Vazquez
Enrique Seoane Vazquez
Chapman University School of Pharmacy
Dirección de correo verificada de chapman.edu - Página principal
TítuloCitado porAño
Market withdrawal of new molecular entities approved in the United States from 1980 to 2009
ZP Qureshi, E Seoane‐Vazquez, R Rodriguez‐Monguio, KB Stevenson, ...
Pharmacoepidemiology and drug safety 20 (7), 772-777, 2011
1122011
Incentives for orphan drug research and development in the United States
E Seoane-Vazquez, R Rodriguez-Monguio, SL Szeinbach, J Visaria
Orphanet journal of rare diseases 3 (1), 33, 2008
1102008
The impact of allergic rhinitis on work productivity
SL Szeinbach, EC Seoane-Vazquez, A Beyer, PB Williams
Primary Care Respiratory Journal 16 (2), 98-105, 2007
722007
Dispensing errors in community pharmacy: perceived influence of sociotechnical factors
S Szeinbach, E Seoane-Vazquez, A Parekh, M Herderick
International Journal for Quality in Health Care 19 (4), 203-209, 2007
572007
Exogenous endoscopy-related infections, pseudo-infections, and toxic reactions: clinical and economic burden
E Seoane-Vazquez, R Rodriguez-Monguio, J Visaria, A Carlson
Current medical research and opinion 22 (10), 2007-2021, 2006
452006
Endoscopy-related infections and toxic reactions: an international comparison
E Seoane-Vazquez, R Rodriguez-Monguio, J Visaria, A Carlson
Endoscopy 39 (08), 742-778, 2007
432007
Endoscopy-related infection: relic of the past?
E Seoane-Vazquez, R Rodriguez-Monguio
Current opinion in infectious diseases 21 (4), 362-366, 2008
392008
Incorporating indications into medication ordering—time to enter the age of reason
G Schiff, E Seoane-Vazquez, A Wright
362016
Approval and withdrawal of new antibiotics and other antiinfectives in the US, 1980–2009
K Outterson, JH Powers, E Seoane‐Vazquez, R Rodriguez‐Monguio, ...
The Journal of Law, Medicine & Ethics 41 (3), 688-696, 2013
342013
International critical care hospital pharmacist activities
JM LeBlanc, EC Seoane-Vazquez, TC Arbo, JF Dasta
Intensive care medicine 34 (3), 538-542, 2008
312008
Evaluation of causes and frequency of medication errors during information technology downtime
TL Hanuscak, SL Szeinbach, E Seoane-Vazquez, BJ Reichert, ...
American Journal of Health-System Pharmacy 66 (12), 1119-1124, 2009
252009
Good research practices for measuring drug costs in cost‐effectiveness analyses: Medicare, Medicaid and other US government payers perspectives: the ISPOR Drug Cost Task Force …
CD Mullins, B Seal, E Seoane‐Vazquez, J Sankaranarayanan, CV Asche, ...
Value in Health 13 (1), 18-24, 2010
242010
Drug utilization and cost in a Medicaid population: A simulation study of community vs. mail order pharmacy
S Valluri, E Seoane-Vazquez, R Rodriguez-Monguio, SL Szeinbach
BMC health services research 7 (1), 122, 2007
242007
Ethical imperatives of timely access to orphan drugs: is possible to reconcile economic incentives and patients’ health needs?
R Rodriguez-Monguio, T Spargo, E Seoane-Vazquez
Orphanet journal of rare diseases 12 (1), 1, 2017
192017
Evaluating catheter complications and outcomes in patients receiving home parenteral nutrition
SL Szeinbach, J Pauline, KF Villa, SR Commerford, A Collins, ...
Journal of evaluation in clinical practice 21 (1), 153-159, 2015
192015
The prevalence of pharmaceutical shortages in the United States
P Le, E Seoane-Vazquez, R Rodriguez-Monguio, ER Fox, SL Szeinbach, ...
Journal of Generic Medicines 8 (4), 210-218, 2011
192011
Negotiating antiretroviral drug prices: the experience of the Andean countries
E Seoane-Vazquez, R Rodriguez-Monguio
Health Policy and Planning 22 (2), 63-72, 2007
192007
Pharmacists’ perceptions of computerized prescriber-order-entry systems
CC Inquilla, S Szeinbach, E Seoane-Vazquez, KH Kappeler
American Journal of Health-System Pharmacy 64 (15), 1626-1632, 2007
182007
Priority review drugs approved by the FDA and the EMA: time for international regulatory harmonization of pharmaceuticals?
S Alqahtani, E Seoane‐Vazquez, R Rodriguez‐Monguio, T Eguale
Pharmacoepidemiology and drug safety 24 (7), 709-715, 2015
172015
Fixed-dose combination drug approvals, patents and market exclusivities compared to single active ingredient pharmaceuticals
J Hao, R Rodriguez-Monguio, E Seoane-Vazquez
PloS one 10 (10), e0140708, 2015
142015
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20